PRODUCTS
SERVICES
COMPANY
CONTACT
FAQ
Search
Dictionary
Mobile
Login
Login/Nickname:
Password:
Remember login
Login
Send password reminder...
Ikuo Saiki Selected Research
Neoplasm Metastasis (Metastasis)
07/2008
Heregulin-induced activation of ErbB3 by EGFR tyrosine kinase activity promotes tumor growth and metastasis in melanoma cells.
03/2008
A ginseng saponin metabolite suppresses tumor necrosis factor-alpha-promoted metastasis by suppressing nuclear factor-kappaB signaling in murine colon cancer cells.
11/2007
Chemokine receptors in cancer metastasis and cancer cell-derived chemokines in host immune response.
06/2006
TAK1-mediated stress signaling pathways are essential for TNF-alpha-promoted pulmonary metastasis of murine colon cancer cells.
01/2006
RANKL-induced CCL22/macrophage-derived chemokine produced from osteoclasts potentially promotes the bone metastasis of lung cancer expressing its receptor CCR4.
01/2006
Preventive effect of oral administration of 6-(methylsulfinyl)hexyl isothiocyanate derived from wasabi (Wasabia japonica Matsum) against pulmonary metastasis of B16-BL6 mouse melanoma cells.
12/2005
Stimulation of cultured colon 26 cells with TNF-alpha promotes lung metastasis through the extracellular signal-regulated kinase pathway.
05/2005
Vanillin suppresses in vitro invasion and in vivo metastasis of mouse breast cancer cells.
03/2005
Urinary trypsin inhibitor suppresses surgical stress-facilitated lung metastasis of murine colon 26-L5 carcinoma cells.
01/2004
Inhibition of lymphangiogenesis-related properties of murine lymphatic endothelial cells and lymph node metastasis of lung cancer by the matrix metalloproteinase inhibitor MMI270.
08/2003
TAC-101 inhibits intrahepatic metastasis of orthotopically implanted murine hepatocellular carcinoma.
05/2003
Inhibitory effects of caffeic acid phenethyl ester analogues on experimental lung metastasis of murine colon 26-L5 carcinoma cells.
01/2003
Prevention of intrahepatic metastasis by curcumin in an orthotopic implantation model.
12/2002
Potential ability of morphine to inhibit the adhesion, invasion and metastasis of metastatic colon 26-L5 carcinoma cells.
07/2002
Prevention of growth and metastasis of murine melanoma through enhanced natural-killer cytotoxicity by fatty acid-conjugate of protopanaxatriol.
04/2002
Morphine analgesia suppresses tumor growth and metastasis in a mouse model of cancer pain produced by orthotopic tumor inoculation.
02/2002
A new pseudo-peptide of Arg-Gly-Asp (RGD) inhibits intrahepatic metastasis of orthotopically implanted murine hepatocellular carcinoma.
Articles by Research Topic
Disease
17
Neoplasm Metastasis (Metastasis)
07/2008 - 02/2002
8
Neoplasms (Cancer)
07/2008 - 04/2002
6
Melanoma (Melanoma, Malignant)
07/2008 - 07/2002
6
Prostatic Neoplasms (Prostate Cancer)
03/2008 - 02/2002
5
Hepatocellular Carcinoma (Hepatoma)
02/2006 - 02/2002
4
Carcinoma (Carcinomatosis)
03/2005 - 10/2002
3
Pain (Aches)
03/2008 - 04/2002
2
Colonic Neoplasms (Colon Cancer)
03/2008 - 06/2006
2
Lung Neoplasms (Lung Cancer)
01/2006 - 01/2004
1
Skin Neoplasms (Skin Cancer)
03/2008
1
Rheumatoid Arthritis
10/2007
1
Lewis Lung Carcinoma
02/2006
1
Breast Neoplasms (Breast Cancer)
05/2005
1
Tissue Adhesions
12/2002
Drug/Important Bio-Agent (IBA)
3
Morphine (MS Contin)
FDA Link
Generic
03/2008 - 04/2002
3
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
03/2008 - 12/2005
2
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
07/2008 - 06/2003
2
Chemokine Receptors
IBA
11/2007 - 10/2006
2
Androgen Receptors (Androgen Receptor)
IBA
10/2006 - 02/2002
2
gefitinib (Iressa)
FDA Link
02/2006 - 06/2003
2
Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))
IBA
06/2005 - 02/2002
2
CGS 27023A
IBA
01/2004 - 01/2003
2
caffeic acid phenethyl ester
IBA
05/2003 - 10/2002
1
Neuregulin-1 (Neuregulin 1)
IBA
07/2008
1
CXCR4 Receptors (CXCR4 Receptor)
IBA
03/2008
1
Saponins
IBA
03/2008
1
Endothelins (Endothelin)
IBA
02/2008
1
Endothelin Receptors (Endothelin Receptor)
IBA
02/2008
1
Chemokines
IBA
11/2007
1
keishibukuryogan
IBA
10/2007
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
04/2007
1
6- (1- hydroxyimino- 4- methylpentyl)- 5,8- dimethoxy- 1,4- naphthoquinone
IBA
02/2006
1
Integrin alphaV
IBA
02/2006
1
Fibronectins (Fibronectin)
IBA
02/2006
1
CCR4 Receptors
IBA
01/2006
1
Chemokine CCL22
IBA
01/2006
1
6-(Methylsulfinyl)hexyl isothiocyanate
IBA
01/2006
1
Phosphotransferases (Kinase)
IBA
12/2005
1
Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)
IBA
06/2005
1
Interleukin-6 (Interleukin 6)
IBA
06/2005
1
vanillin
IBA
05/2005
1
urinastatin (MR 20)
IBA
03/2005
1
bestatin (ubenimex)
IBA
12/2004
1
Chromogranin A
IBA
09/2003
1
retinoic acid receptor alpha
IBA
09/2003
1
TAC 101
IBA
08/2003
1
Hepatocyte Growth Factor (Growth Factor, Hepatocyte)
IBA
07/2003
1
Epidermal Growth Factor Receptor (EGF Receptor)
IBA
06/2003
1
gabapentin (Neurontin)
FDA Link
Generic
04/2003
1
Curcumin
IBA
01/2003
1
alpha-galactosylceramide
IBA
09/2002
1
protopanaxatriol
IBA
07/2002
1
arginyl-glycyl-aspartic acid
IBA
02/2002
Therapy/Procedure
1
Traditional Medicine (Folk Remedies)
10/2007
1
Kampo Medicine (Kampo)
10/2007
1
Analgesia
04/2002